Loading…
Loading…
what are the milestones that are left regarding the completion of the Saudi plant?
just to be clear, you'll give us an update in Q2 regarding the production guidance as well as the CapEx guidance.
do you foresee any bottlenecks or any issues to the time line for the construction there?
how should we think about the unit mix for that guidance for this year between Air, Gravity, possibly some midsize?
how are you thinking about capital needs and maybe cash burn between now and then?
how the contract with the government of Saudi Arabia, the one up for 50,000 plus, another option for 50,000.
I'm curious if you can maybe refresh us on near-term capital needs.
as the macro worsens if you're expecting any changes to initial ASPs once it's available.
can you just remind us the plans regarding the 2026 convertible that's coming up?
can you remind us again kind of the plan to address the convertible bonds maturing in 2026?
how should we think about the breakdown between the Sedans and the Gravity, both in terms of maybe production
what does the path to profitable gross margins look like from a timeline perspective?
do you expect any changes to ASPs, particularly off the R2 line?
how are you thinking about ASPs going forward?
what are the key items that are pending that investors and ourselves should be tracking
does this include the 40% of revenue from SDA Tranche II 10% of maybe the Tranche III?
can you remind us the revenue recognition associated with the FDA tranche two award.
what does the revenue recognition look like for the SDA tranche 2 awards, both for this year and for next year?
with the international space budgets growing, how do you expect this can benefit Rocket Lab?
how confident are you in launching this year? And as we look into 2026, how should we think about the revenue mix